WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2002028881) BILE-ACID DERIVED COMPOUNDS FOR PROVIDING SUSTAINED SYSTEMIC CONCENTRATIONS OF DRUGS AFTER ORAL ADMINISTRATION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2002/028881    International Application No.:    PCT/US2001/042513
Publication Date: 11.04.2002 International Filing Date: 05.10.2001
Chapter 2 Demand Filed:    19.04.2002    
IPC:
A61K 38/00 (2006.01), A61K 47/48 (2006.01), C07C 237/12 (2006.01), C07C 237/20 (2006.01), C07C 323/60 (2006.01), C07D 207/16 (2006.01), C07D 233/54 (2006.01), C07K 5/02 (2006.01)
Applicants: XENOPORT, INC. [US/US]; 2631 Hanover Street, Palo Alto, CA 94304 (US) (For All Designated States Except US).
GALLOP, Mark, A. [NZ/US]; (US) (For US Only).
CUNDY, Kenneth, C. [US/US]; (US) (For US Only).
ZHOU, Cindy, X. [US/US]; (US) (For US Only)
Inventors: GALLOP, Mark, A.; (US).
CUNDY, Kenneth, C.; (US).
ZHOU, Cindy, X.; (US)
Agent: SWISS, Gerald, F.; Burns, Doane, Swecker & Mathis, L.L.P., P.O. Box 1404, Alexandria, VA 22313-1404 (US)
Priority Data:
60/238,758 06.10.2000 US
60/249,804 17.11.2000 US
60/297,594 11.06.2001 US
Title (EN) BILE-ACID DERIVED COMPOUNDS FOR PROVIDING SUSTAINED SYSTEMIC CONCENTRATIONS OF DRUGS AFTER ORAL ADMINISTRATION
(FR) COMPOSES DERIVES D'ACIDE BILIAIRE ASSURANT DES CONCENTRATIONS SYSTEMIQUES PROLONGEES DE MEDICAMENTS APRES ADMINISTRATION PAR VOIE ORALE
Abstract: front page image
(EN)This invention is directed to methods for providing sustained systemic concentrations of therapeutic or prophylactic agents such as GABA analogs following oral administration to animals. This invention is also directed to compounds and pharmaceutical compositions that are used in such methods.
(FR)La présente invention concerne des procédés permettant d'assurer des concentrations systémiques prolongées d'agents thérapeutiques ou prophylactiques, tels que des analogues de GABA, après administration par voie orale à des animaux. La présente invention concerne également des composés et des compositions pharmaceutiques mis en oeuvre dans ces procédés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PH, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)